In vitro and in vivo evidence suggesting a role for iron in cisplatin- induced nephrotoxicity

Kidney International

Volumn 53, Issue 2, 1998, Pages 394-401

  Baliga, Radhakrishna ^b   Zhang, Zhiwei ^b   Baliga, Mithra ^b   Ueda, Norishi ^b   Shah, Sudhir V ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b NONE

Author keywords

Antineoplastic agent; Cisplatin induced nephrotoxicity; Hydroxyl radicals; Iron in nephrotoxicity; Nephrotoxicity; Tissue injury

Indexed keywords

1,10 PHENANTHROLINE; ANTINEOPLASTIC AGENT; BLEOMYCIN; CISPLATIN; DEFEROXAMINE; IRON;

ACUTE KIDNEY FAILURE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; DRUG EFFECT; IRON CHELATION; IRON TRANSPORT; KIDNEY TUBULE EPITHELIUM; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0031933285     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1998.00767.x     Document Type: Article

References (34)

1. ROZENCWEIG M, VON HOFF DD, SLAVIK M, MUGGIA FM: Cisdiamminedichloroplatinum (II). A new anticancer drug. Ann Int Med 86:803-812, 1977
2. BLACHLEY JD, HILL JB: Renal and electrolyte disturbances associated with cisplatin. Ann Int Med 95:628-632, 1981
3. OZOLS RF, YOUNG RC: High-dose cisplatin therapy in ovarian cancer. Semin Oncol 12(Suppl 6):21-30, 1985
4. SAFIRSTEIN R, WINSTON J, MOEL D, DIKMAN S, GUTTENPLAN J: Cisplatin nephrotoxicity: Insights into mechanism. Int J Androl 10: 325-346, 1987
5. HALLIWELL B, GUTTERIDGE JMC: Role of free radicals and catalytic metal ions in human disease: An overview. Meth Enzymol 186:1-85, 1990
6. GUTTERIDGE JMC, ROWLEY DA, HALLIWELL B, WESTERMARCK T: Increased non-protein-bound iron and decreased protection against superoxide-radical damage in cerebrospinal fluid from patients with neuronal ceroid lipofuscinoses. Lancet 2:459-460, 1982
7. BALIGA R, UEDA N, SHAH SV: Increase in bleomycin-detectable iron in ischaemia/reperfusion injury to rat kidneys. Biochem J 291:901-905, 1993
8. BALIGA R, ZHANG Z, BALIGA M, SHAH SV: Evidence for cytochrome P-450 as a source of catalytic iron in myoglobinuric acute renal failure. Kidney Int 49:362-369, 1996
9. WALKER PD, SHAH SV: Evidence suggesting a role for hydroxyl radical in gentamicin-induced acute renal failure in rats. J Clin Invest 81:334-341, 1988
10. PALLER MS, HEDLUND BE: Role of iron in postischemic renal injury in the rat. Kidney Int 34:474-480, 1988
11. SHAH SV, WALKER PD: Evidence suggesting a role for hydroxyl radical in glycerol-induced acute renal failure. Am J Physiol 255:F438-F443, 1988
12. PALLER MS, NEUMANN TV: Reactive oxygen species and rat renal epithelial cells during hypoxia and reoxygenation. Kidney Int 40:1041-1049, 1991
13. 1 cells: A role for iron. Kidney Int 40:891-898, 1991
14. 1 cells as a model for cis-diamminedichloroplatinum(II) nephrotoxicity and modulation by thiol rescue agents. Cancer Res 48:6017-6024, 1988
15. 1 cells. Biochem Pharmacol 44:382-387, 1992
16. HALLIWELL B, GROOTVELD M, GUTTERIDGE JMC: Methods for the measurement of hydroxyl radicals in biochemical systems: Deoxyribose degradation and aromatic hydroxylation. Meth Biochem Anal 33:59-90, 1988
17. CAPASSO G, GIORDANO DR, DE TOMMASO G, DE SANTO NG, MASSRY SG: Parathyroidectomy has a beneficial effect on experimental cisplatin nephrotoxicity. Clin Nephrol 33:184-191, 1990
18. ABUL-EZZ SR, WALKER PD, SHAH SV: Role of glutathione in an animal model of myoglobinuric acute renal failure. Proc Natl Acad Sci USA 88:9833-9837, 1991
19. ZAGER RA: Combined mannitol and deferoxamine therapy for myohemoglobinuric renal injury and oxidant tubular stress. Mechanistic and therapeutic implications. J Clin Invest 90:711-719, 1992
20. 1 cells. Kidney Int 50:1118-1124, 1996
21. AL-HARBI MM, AL-GHARABLY NM, AL-SHABANAH OA, AL-BEKAIRI AM, OSMAN AMM, TAWFIK HN: Prevention of doxorubicin-induced myocardial and haematological toxicities in rats by the iron chelator desferrioxamine. Cancer Chemother Pharmacol 31:200-204, 1992
22. AL-BEKAIRI AM, OSMAN AMM, HAFEEZ MA, AL-GHARABLY NM, AL-SHABANAH OA, AL-HARBI MM: Effect of desferrioxamine on the hepatoxicity of adriamycin in normal mice. Drug Dev Res 29:56-62, 1993
23. MATSUKI N, TORII Y, SAITO H: Effects of iron and deferoxamine on cisplatin-induced emesis: Further evidence for the role of free radicals. Eur J Pharmacol 248:329-331, 1993
24. AL-HARBI MM, OSMAN AMM, AL-GHARABLY NM, AL-BEKAIRI AM, AL-SHABANAH OA, SABAH DM, RAZA M: Effect of desferrioxamine on cisplatin-induced nephrototoxicity in normal rats. Chemotherapy 41:448-454, 1995
25. PALLER MS, JACOB HS: Cytochrome P-450 mediates tissue-damaging hydroxyl radical formation during reoxygenation of the kidney. Proc Natl Acad Sci USA 91:7002-7006, 1994
26. PALLER MS, HOIDAL JR, FERRIS TF: Oxygen free radicals in ischemic acute renal failure in the rat. J Clin Invest 74:1156-1164, 1984
27. MASUDA H, TANAKA T, TAKAHAMA U: Cisplatin generates superoxide anion by interaction with DNA in a cell-free system. Biochem Biophys Res Commun 203:1175-1180, 1994
28. ANDREOLI SP, MCATEER JA: Reactive oxygen molecule-mediated injury in endothelial and renal tubular epithelial cells in vitro. Kidney Int 38:785-794, 1990
29. UEDA N, SHAH SV: Endonuclease-induced DNA damage and cell death in oxidant injury to renal tubular epithelial cells. J Clin Invest 90:2593-2597, 1992
30. LIEBERTHAL W, TRIACA V, LEVINE J: Mechanisms of death induced by cisplatin in proximal tubular epithelial cells: Apoptosis vs. necrosis. Am J Physiol 270:F700-F708, 1996
31. HANNEMANN J, BAUMANN K: Cisplatin-induced lipid peroxidation and decrease of gluconeogenesis in rat kidney cortex: Different effects of antioxidants and radical scavengers. Toxicology 51:119-132, 1988
32. NAKANO S, GEMBA M: Potentiation of cisplatin-induced lipid peroxidation in kidney cortical slices by glutathione depletion. Jpn J Pharmacol 50:87-92, 1989
33. SUGIHARA K, GEMBA M: Modification of cisplatin toxicity by antioxidants. Jpn J Pharmacol 40:353-355, 1986
34. GEMBA M, FUKUISHI N: Amelioration by ascorbic acid of cisplatin-induced injury in cultured renal epithelial cells. Contrib Nephrol 95:138-142, 1991